Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
58 "Mucin"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Article image
TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases
Yi A. Liu, Phyu P. Aung, Yunyi Wang, Jing Ning, Priyadharsini Nagarajan, Jonathan L. Curry, Carlos A. Torres-Cabala, Doina Ivan, Victor G. Prieto, Qingqing Ding, Woo Cheal Cho
J Pathol Transl Med. 2024;58(2):72-80.   Published online February 26, 2024
DOI: https://doi.org/10.4132/jptm.2024.01.23
  • 2,181 View
  • 302 Download
  • 3 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary Material
Background
Although trichorhinophalangeal syndrome type 1 (TRPS1) was initially thought to be highly sensitive and specific for carcinomas and mesenchymal tumors of mammary origin, more recent data suggest its expression is not limited to breast neoplasms but also can be seen in other cutaneous neoplasms, such as extramammary Paget disease and squamous cell carcinoma (SCC) in situ.
Methods
Two-hundred cases of non-melanocytic cutaneous neoplasm, including basal cell carcinomas (BCCs) (n = 41), SCCs (n = 35), Merkel cell carcinomas (MCCs) (n = 25), and adnexal neoplasms (n = 99), were tested for TRPS1 expression using a monoclonal anti- TRPS1 rabbit anti-human antibody.
Results
TRPS1 expression was present in almost all cases of SCC (94%), with a median H-score of 200, while it was either absent or only focally present in most BCCs (90%), with a median H-score of 5. The difference between BCCs and SCCs in H-score was significant (p < .001). All MCCs (100%) lacked TRPS1 expression. TRPS1 expression was frequently seen in most adnexal neoplasms, benign and malignant, in variable intensity and proportion but was consistently absent in apocrine carcinomas. All endocrine mucin-producing sweat gland carcinomas (EMPSGCs) (100%, 6/6) showed diffuse and strong TRPS1 immunoreactivity, with a median H-score of 300, which was significantly different (p < .001) than that of BCCs.
Conclusions
Our study shows that TRPS1 may be an effective discriminatory marker for BCCs and SCCs. It also has a role in distinguishing BCCs from EMPSGCs.

Citations

Citations to this article as recorded by  
  • TRPS1 Expression Is Frequently Seen in a Subset of Cutaneous Mesenchymal Neoplasms and Tumors of Uncertain Differentiation: A Potential Diagnostic Pitfall
    Moon Joo Kim, Yi A. Liu, Yunyi Wang, Jing Ning, Woo Cheal Cho
    Dermatopathology.2024; 11(3): 200.     CrossRef
  • TRPS1 expression in MPNST is correlated with PRC2 inactivation and loss of H3K27me3
    Rossana Lazcano, Davis R. Ingram, Gauri Panse, Alexander J. Lazar, Wei-Lien Wang, Jeffrey M. Cloutier
    Human Pathology.2024; 151: 105632.     CrossRef
  • Syringocystadenoma Papilliferum-Like Features in Poroma: An Unusual Morphologic Pattern of Poroma or True Synchronous Occurrence of 2 Distinct Neoplasms?
    Mouaz Alsawas, Fiorinda F. Muhaj, Phyu P. Aung, Priyadharsini Nagarajan, Woo Cheal Cho
    The American Journal of Dermatopathology.2024; 46(12): 871.     CrossRef
  • A Comprehensive Review of TRPS1 as a Diagnostic Immunohistochemical Marker for Primary Breast Carcinoma: Latest Insights and Diagnostic Pitfalls
    Antonia-Carmen Georgescu, Tiberiu-Augustin Georgescu, Simona-Alina Duca-Barbu, Lucian Gheorghe Pop, Daniela Oana Toader, Nicolae Suciu, Dragos Cretoiu
    Cancers.2024; 16(21): 3568.     CrossRef
  • Expression of TRPS1 in Metastatic Tumors of the Skin: An Immunohistochemical Study of 72 Cases
    Kassiani Boulogeorgou, Christos Topalidis, Triantafyllia Koletsa, Georgia Karayannopoulou, Jean Kanitakis
    Dermatopathology.2024; 11(4): 293.     CrossRef
Review
Article image
Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms
Dong-Wook Kang, Baek-hui Kim, Joon Mee Kim, Jihun Kim, Hee Jin Chang, Mee Soo Chang, Jin-Hee Sohn, Mee-Yon Cho, So-Young Jin, Hee Kyung Chang, Hye Seung Han, Jung Yeon Kim, Hee Sung Kim, Do Youn Park, Ha Young Park, So Jeong Lee, Wonae Lee, Hye Seung Lee, Yoo Na Kang, Younghee Choi
J Pathol Transl Med. 2021;55(4):247-264.   Published online July 8, 2021
DOI: https://doi.org/10.4132/jptm.2021.05.28
  • 10,860 View
  • 832 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFSupplementary Material
Although the understanding of appendiceal mucinous neoplasms (AMNs) and their relationship with disseminated peritoneal mucinous disease have advanced, the diagnosis, classification, and treatment of AMNs are still confusing for pathologists and clinicians. The Gastrointestinal Pathology Study Group of the Korean Society of Pathologists (GPSG-KSP) proposed a multicenter study and held a workshop for the “Standardization of the Pathologic Diagnosis of the Appendiceal Mucinous Neoplasm” to overcome the controversy and potential conflicts. The present article is focused on the diagnostic criteria, terminologies, tumor grading, pathologic staging, biologic behavior, treatment, and prognosis of AMNs and disseminated peritoneal mucinous disease. In addition, GPSG-KSP proposes a checklist of standard data elements of appendiceal epithelial neoplasms to standardize pathologic diagnosis. We hope the present article will provide pathologists with updated knowledge on how to handle and diagnose AMNs and disseminated peritoneal mucinous disease.

Citations

Citations to this article as recorded by  
  • Lower Gastrointestinal Bleeding Secondary to Appendiceal Mucinous Neoplasm: A Report of Two Cases and a Review of the Literature
    Jesús Omar Soto Llanes, Samanta Kin Dosal Limón, Ana Jimena Iberri Jaime, Mario Zambrano Lara, Billy Jiménez Bobadilla
    Cureus.2024;[Epub]     CrossRef
  • Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology
    Paul H. McClelland, Stephanie N. Gregory, Shirley K. Nah, Jonathan M. Hernandez, Jeremy L. Davis, Andrew M. Blakely
    Annals of Surgical Oncology.2024; 31(9): 6237.     CrossRef
  • Histoséminaire biopsies péritonéales tumorales. Néoplasies mucineuses appendiculaires
    Peggy Dartigues
    Annales de Pathologie.2024; 44(4): 274.     CrossRef
  • Histoséminaire biopsies péritonéales tumorales. Cas no 2
    Peggy Dartigues
    Annales de Pathologie.2024; 44(4): 245.     CrossRef
  • A Case of Low-Grade Appendiceal Mucinous Neoplasm: The Role of Preoperative Imaging and Surgical Technique in Achieving Favorable Outcomes
    Daniel A Meza-Martinez, Yeudiel Suro Santos, Samantha J Andrade-Ordoñez, Julio A Palomino-Payan, Brando J Fematt-Rodriguez
    Cureus.2024;[Epub]     CrossRef
  • Incidental Appendiceal Mucinous Neoplasm Found During Appendectomy in a 15-Year-Old Patient: A Case Report
    Fernando Aguilar-Ruiz, Kevin Joseph Fuentes-Calvo, Sara Fernanda Arechavala-Lopez, Irving Fuentes-Calvo, Luis F Arias-Ruiz
    Cureus.2024;[Epub]     CrossRef
  • Uncovering the Hidden Threat: Ileocolic Intussusception in an Adult With Appendicular Tumor
    Mrunal Panchal, Shishir Kumar, Khushboo Jha, Kaushik Saha, Abhijit Kundu
    Cureus.2024;[Epub]     CrossRef
  • Appendiceal perforation secondary to endometriosis with intestinal metaplasia: A case report
    Minghua Wang, Jing Liu, Boxin Hu, Simin Wang, Ping Xie, Ping Li
    Experimental and Therapeutic Medicine.2023;[Epub]     CrossRef
  • Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation
    Javier Miguez González, Francesc Calaf Forn, Laura Pelegrí Martínez, Pilar Lozano Arranz, Rafael Oliveira Caiafa, Jordi Català Forteza, Lina Maria Palacio Arteaga, Ferrán Losa Gaspà, Isabel Ramos Bernadó, Pedro Barrios Sánchez, Juan Ramón Ayuso Colella
    Insights into Imaging.2023;[Epub]     CrossRef
  • Muzinöse Tumoren des Peritoneums
    Anne Kristin Fischer, Andrea Tannapfel, Alexander Quaas
    Die Chirurgie.2023; 94(10): 823.     CrossRef
  • Landscape of Genetic Mutations in Appendiceal Cancers
    Marian Constantin, Cristina Mătanie, Livia Petrescu, Alexandra Bolocan, Octavian Andronic, Coralia Bleotu, Mihaela Magdalena Mitache, Sorin Tudorache, Corneliu Ovidiu Vrancianu
    Cancers.2023; 15(14): 3591.     CrossRef
  • Delivery of an Incidental Appendiceal Mucinous Neoplasm
    Madison Bowles, Jessica Y Ng, Hajir Nabi
    Cureus.2022;[Epub]     CrossRef
  • Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing
    Sungbin An, Hyun Hee Koh, Eun Sol Chang, Juyoung Choi, Ji-Young Song, Mi-Sook Lee, Yoon-La Choi
    Frontiers in Oncology.2022;[Epub]     CrossRef
Original Article
Article image
Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
Yunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Cho
J Pathol Transl Med. 2020;54(1):95-102.   Published online November 13, 2019
DOI: https://doi.org/10.4132/jptm.2019.10.24
  • 7,583 View
  • 274 Download
  • 19 Web of Science
  • 18 Crossref
AbstractAbstract PDF
Background
Pure mucinous carcinoma (PMC) is a rare type of breast cancer, estimated to represent 2% of invasive breast cancer. PMC is typically positive for estrogen receptors (ER) and progesterone receptors (PR) and negative for human epidermal growth factor receptor 2 (HER2). The clinicopathologic characteristics of HER2-positive PMC have not been investigated.
Methods
Pathology archives were searched for PMC diagnosed from January 1999 to April 2018. Clinicopathologic data and microscopic findings were reviewed and compared between HER2-positive PMC and HER2-negative PMC. We also analyzed the differences in disease-free survival (DFS) and overall survival according to clinicopathologic parameters including HER2 status in overall PMC cases.
Results
There were 21 HER2-positive cases (4.8%) in 438 PMCs. The average tumor size of HER2-positive PMC was 32.21 mm (± 26.55). Lymph node metastasis was present in seven cases. Compared to HER2-negative PMC, HER2-positive PMC presented with a more advanced T category (p < .001), more frequent lymph node metastasis (p = .009), and a higher nuclear and histologic grade (p < .001). Microscopically, signet ring cells were frequently observed in HER2-positive PMC (p < .001), whereas a micropapillary pattern was more frequent in HER2-negative PMC (p = .012). HER2-positive PMC was more frequently negative for ER (33.3% vs. 1.2%) and PR (28.6% vs. 7.2%) than HER2-negative PMC and showed a high Ki-67 labeling index. During follow-up, distant metastasis and recurrence developed in three HER2-positive PMC patients. Multivariate analysis revealed that only HER2-positivity and lymph node status were significantly associated with DFS.
Conclusions
Our results suggest that HER2-positive PMC is a more aggressive subgroup of PMC. HER2 positivity should be considered for adequate management of PMC.

Citations

Citations to this article as recorded by  
  • Poor response of HER2-positive mucinous carcinomas of breast to neoadjuvant HER2-targeted therapy: A study of four cases
    Min Han, Daniel Schmolze, Javier A. Arias-Stella, Christina H. Wei, Joanne Mortimer, Fang Fan
    Annals of Diagnostic Pathology.2025; 74: 152396.     CrossRef
  • Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma
    Yurimi Lee, Sangjoon Choi, Hyun-Soo Kim
    International Journal of Gynecological Pathology.2024; 43(3): 221.     CrossRef
  • Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 6-years study from national cancer center in Vietnam
    Thi Huyen Phung, Thanh Tung Pham, Huu Thang Nguyen, Dinh Thach Nguyen, Thanh Long Nguyen, Thi Hoai Hoang
    Breast Cancer Research and Treatment.2024;[Epub]     CrossRef
  • Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure
    Beibei Yang, Menglu Shen, Bo Sun, Jing Zhao, Meng Wang
    Thoracic Cancer.2024;[Epub]     CrossRef
  • Pure Mucinous Carcinoma of the Breast: Radiologic-Pathologic Correlation
    Cherie M Kuzmiak, Benjamin C Calhoun
    Journal of Breast Imaging.2023;[Epub]     CrossRef
  • Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer
    Elahe Abdollahi, Hossein Mozdarani, Behrooz Z. Alizadeh
    Breast Cancer.2023; 30(5): 714.     CrossRef
  • On Ultrasonographic Features of Mucinous Carcinoma with Micropapillary Pattern
    Wei-Sen Yang, Yang Li, Ya Gao
    Breast Cancer: Targets and Therapy.2023; Volume 15: 473.     CrossRef
  • Spectrum of Mucin-containing Lesions of the Breast: Multimodality Imaging Review with Pathologic Correlation
    Janice N. Thai, Melinda F. Lerwill, Shinn-Huey S. Chou
    RadioGraphics.2023;[Epub]     CrossRef
  • Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics
    Hyun Hee Koh, Eunhyang Park, Hyun-Soo Kim
    Diagnostics.2022; 12(2): 326.     CrossRef
  • Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics
    Yurimi Lee, Kiyong Na, Ha Young Woo, Hyun-Soo Kim
    Diagnostics.2022; 12(5): 1102.     CrossRef
  • Metastasis of the Mucionous adenocarcinoma of breast to the mandibular gingiva: Rare case report
    Ivana Mijatov, Aleksandra Fejsa Levakov, Aleksandar Spasić, Jelena Nikolić, Saša Mijatov
    Medicine.2022; 101(38): e30732.     CrossRef
  • Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses
    Jihee Sohn, Yurimi Lee, Hyun-Soo Kim
    Diagnostics.2022; 12(10): 2339.     CrossRef
  • Serous Carcinoma of the Endometrium with Mesonephric-Like Differentiation Initially Misdiagnosed as Uterine Mesonephric-Like Adenocarcinoma: A Case Report with Emphasis on the Immunostaining and the Identification of Splice Site TP53 Mutation
    Sangjoon Choi, Yoon Yang Jung, Hyun-Soo Kim
    Diagnostics.2021; 11(4): 717.     CrossRef
  • HER2 positive mucinous carcinoma of breast with micropapillary features: Report of a case and review of literature
    Dinesh Chandra Doval, Rupal Tripathi, Sunil Pasricha, Pankaj Goyal, Chaturbhuj Agrawal, Anurag Mehta
    Human Pathology: Case Reports.2021; 25: 200531.     CrossRef
  • Carcinoma mucosecretor de mama HER2-positivo, un caso clínico
    A.M. González Aranda, E. Martínez Gómez, A. Santana Costa, F. Arnanz Velasco, M.H. González de Diego, A. Zapico Goñi
    Clínica e Investigación en Ginecología y Obstetricia.2021; 48(4): 100685.     CrossRef
  • Clinicopathologic features of unexpectedly HER2 positive breast carcinomas: An institutional experience
    Carissa LaBoy, Kalliopi P. Siziopikou, Lauren Rosen, Luis Z. Blanco, Jennifer L. Pincus
    Pathology - Research and Practice.2021; 222: 153441.     CrossRef
  • Mesonephric-like Differentiation of Endometrial Endometrioid Carcinoma: Clinicopathological and Molecular Characteristics Distinct from Those of Uterine Mesonephric-like Adenocarcinoma
    Sujin Park, Go Eun Bae, Jiyoung Kim, Hyun-Soo Kim
    Diagnostics.2021; 11(8): 1450.     CrossRef
  • Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors
    Hyunjin Kim, Kiyong Na, Go Eun Bae, Hyun-Soo Kim
    Diagnostics.2021; 11(11): 2042.     CrossRef
Case Studies
Coexisting Mucinous Cystic Neoplasm of the Pancreas and Type 1 Autoimmune Pancreatitis
Mee-Jeong Kim, Tae Jun Song, Hyoung Jung Kim, Song-Cheol Kim, Myung-Hwan Kim, Seung-Mo Hong
J Pathol Transl Med. 2019;53(2):125-128.   Published online November 14, 2018
DOI: https://doi.org/10.4132/jptm.2018.10.25
  • 8,266 View
  • 121 Download
  • 3 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Type 1 autoimmune pancreatitis (AIP1) is an IgG4-related systemic disease that mimics tumors. We report a rare case of AIP1 accompanied by mucinous cystic neoplasm (MCN). A pancreatic lesion was incidentally detected in a woman in her 60s. After 6 years of follow-up, the lesion abruptly increased in size. Computed tomography showed a 3.5 cm unilocular cyst in the tail of the pancreas and distal pancreatectomy was performed. On microscopic examination, the cyst was lined by mucinous and non-mucinous epithelial cells with mild cytologic atypia. The surrounding stroma comprised ovarian-type spindle cells with progesterone receptor positivity. The pericystic pancreas exhibited multifocal lymphoid follicles, lymphoplasmacytic infiltrations, obliterative phlebitis, and storiform fibrosis. IgG4-positive plasma cell infiltration (215 cells high-power field) and the IgG4/IgG ratio (57%) were increased. Cases of MCN coexisting with AIP1 are extremely rare; only two such cases have been reported in the English-language literature. This third case featured low-grade MCN with AIP1.

Citations

Citations to this article as recorded by  
  • Utilizing Immunoglobulin G4 Immunohistochemistry for Risk Stratification in Patients with Papillary Thyroid Carcinoma Associated with Hashimoto Thyroiditis
    Faridul Haq, Gyeongsin Park, Sora Jeon, Mitsuyoshi Hirokawa, Chan Kwon Jung
    Endocrinology and Metabolism.2024; 39(3): 468.     CrossRef
  • Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Kenji NOTOHARA
    Choonpa Igaku.2023; 50(1): 55.     CrossRef
  • Imaging Features and Risk Factors of Pancreatic Cystic Lesions Complicating Autoimmune Pancreatitis: A Retrospective Study
    Bin-Bin Zhang, Xin-Meng Hou, Yu-Qi Chen, Jian-Wei Huo, Er-Hu Jin
    Current Medical Imaging Formerly Current Medical Imaging Reviews.2023;[Epub]     CrossRef
  • Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Kenji Notohara
    Journal of Medical Ultrasonics.2021; 48(4): 581.     CrossRef
  • 自己免疫性膵炎診療ガイドライン2020

    Suizo.2020; 35(6): 465.     CrossRef
  • Mucinous cystic neoplasm of the pancreas with type-1 autoimmune pancreatitis-like lesion
    Kevin Gowing, David F. Schaeffer, Hui-Min Yang
    Human Pathology: Case Reports.2019; 18: 200339.     CrossRef
Primary Cutaneous Mucinous Carcinoma with Extramammary Paget’s Disease: Eccrine or Apocrine?
Sun-Ju Oh, Young-Ok Kim
J Pathol Transl Med. 2018;52(4):238-242.   Published online January 25, 2018
DOI: https://doi.org/10.4132/jptm.2017.11.21
  • 6,949 View
  • 133 Download
  • 3 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Primary cutaneous mucinous carcinoma (PCMC) is an uncommon tumor of the sweat gland origin. The occurrence of PCMC is mostly in middle-aged and older patients, with a slight male predominance. Most cases of PCMC arise on the head, with a preference for eyelids. The histogenesis of PCMC, whether eccrine or apocrine, remains controversial. We report a rare case of PCMC with secondary extramammary Paget’s disease in the groin of a 75-year-old man, which favored an apocrine origin. Furthermore, based on a review of the literature, we provide several histologic clues that can be used to differentiate PCMC from metastatic mucinous carcinoma.

Citations

Citations to this article as recorded by  
  • Primary cutaneous mucinous carcinoma of the scalp masquerading as a benign dermatological mass – A case report
    Fadi Alnehlaoui, Nafad Mohamed Lotfy Elhadidi, Shafik Fwakhrji, Shekhar V. Shikare, Majid Hassan Alhammadi, Salman Yousuf Guraya
    International Journal of Surgery Case Reports.2024; 114: 109175.     CrossRef
  • Primary cutaneous mucinous carcinoma in a periorbital lesion: two case reports and literature review
    Jun Woo Kim, Sung Eun Kim
    Archives of Craniofacial Surgery.2024; 25(2): 90.     CrossRef
  • Primary Cutaneous Mucinous Carcinoma: A Review of the Literature
    Timothy Freeman, Aaron J. Russell, M. Laurin Council
    Dermatologic Surgery.2023; 49(12): 1091.     CrossRef
  • A Case of Eccrine Mucinous Carcinoma Involving Scalp
    Ramsha Saleem, Sachin Vaidya
    Cureus.2021;[Epub]     CrossRef
Original Article
Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma
Hyun-Jung Kim, Kyeongmee Park, Jung Yeon Kim, Guhyun Kang, Geumhee Gwak, Inseok Park
J Pathol Transl Med. 2017;51(4):403-409.   Published online June 9, 2017
DOI: https://doi.org/10.4132/jptm.2017.03.18
  • 6,930 View
  • 198 Download
  • 16 Web of Science
  • 18 Crossref
AbstractAbstract PDF
Background
Mucinous carcinoma of the breast is an indolent tumors with a favorable prognosis; however, micropapillary features tend to lead to aggressive behavior. Thus, mucinous carcinoma and micropapillary carcinoma exhibit contrasting biologic behaviors. Here, we review invasive mucinous carcinoma with a focus on micropapillary features and correlations with clinicopathological factors.
Methods
A total of 64 patients with invasive breast cancer with mucinous or micropapillary features were enrolled in the study. Of 36 pure mucinous carcinomas, 17 (47.2%) had micropapillary features and were termed mucinous carcinoma with micropapillary features (MUMPC), and 19 (52.8%) had no micropapillary features and were termed mucinous carcinoma without micropapillary features. MUMPC were compared with 15 invasive micropapillary carcinomas (IMPC) and 13 invasive ductal and micropapillary carcinomas (IDMPC).
Results
The clinicopathological factors of pure mucinous carcinoma and MUMPC were not significantly different. In contrast to IMPC and IDMPC, MUMPC had a low nuclear grade, lower mitotic rate, higher expression of hormone receptors, negative human epidermal growth factor receptor 2 (HER2) status, lower Ki-67 proliferating index, and less frequent lymph node metastasis (p < .05). According to univariate analyses, progesterone receptor, HER2, T-stage, and lymph node metastasis were significant risk factors for overall survival; however, only T-stage remained significant in a multivariate analysis (p < .05).
Conclusions
In contrast to IMPC and IDMPC, the micropapillary pattern in mucinous carcinoma does not contribute to aggressive behavior. However, further analysis of a larger series of patients is required to clarify the prognostic significance of micropapillary patterns in mucinous carcinoma of the breast.

Citations

Citations to this article as recorded by  
  • Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
    Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
    Clinical Case Reports.2024;[Epub]     CrossRef
  • Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure
    Beibei Yang, Menglu Shen, Bo Sun, Jing Zhao, Meng Wang
    Thoracic Cancer.2024;[Epub]     CrossRef
  • Expression of autocrine motility factor receptor (AMFR) in human breast and lung invasive micropapillary carcinomas
    Jing Xu, Hongfei Ma, Qi Wang, Hui Zhang
    International Journal of Experimental Pathology.2023; 104(1): 43.     CrossRef
  • The Spectrum of Mucinous Lesions of the Breast
    Upasana Joneja, Juan Palazzo
    Archives of Pathology & Laboratory Medicine.2023; 147(1): 19.     CrossRef
  • Pure Mucinous Carcinoma of the Breast: Radiologic-Pathologic Correlation
    Cherie M Kuzmiak, Benjamin C Calhoun
    Journal of Breast Imaging.2023; 5(2): 180.     CrossRef
  • On Ultrasonographic Features of Mucinous Carcinoma with Micropapillary Pattern
    Wei-Sen Yang, Yang Li, Ya Gao
    Breast Cancer: Targets and Therapy.2023; Volume 15: 473.     CrossRef
  • Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis
    Georgios-Ioannis Verras, Levan Tchabashvili, Francesk Mulita, Ioanna Maria Grypari, Sofia Sourouni, Evangelia Panagodimou, Maria-Ioanna Argentou
    Breast Cancer: Targets and Therapy.2022; Volume 14: 41.     CrossRef
  • Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
    Minjung Jung
    Kosin Medical Journal.2022; 37(3): 176.     CrossRef
  • Triple-Positive Breast Carcinoma: Histopathologic Features and Response to Neoadjuvant Chemotherapy
    Jennifer Zeng, Marcia Edelweiss, Dara S. Ross, Bin Xu, Tracy-Ann Moo, Edi Brogi, Timothy M. D'Alfonso
    Archives of Pathology & Laboratory Medicine.2021; 145(6): 728.     CrossRef
  • HER2 positive mucinous carcinoma of breast with micropapillary features: Report of a case and review of literature
    Dinesh Chandra Doval, Rupal Tripathi, Sunil Pasricha, Pankaj Goyal, Chaturbhuj Agrawal, Anurag Mehta
    Human Pathology: Case Reports.2021; 25: 200531.     CrossRef
  • Sonographic Features of Pure Mucinous Breast Carcinoma With Micropapillary Pattern
    Wu Zhou, Yong-Zhong Li, Li-Min Gao, Di-Ming Cai
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
    Yunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Cho
    Journal of Pathology and Translational Medicine.2020; 54(1): 95.     CrossRef
  • Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast
    Peng Sun, Zaixuan Zhong, Qianyi Lu, Mei Li, Xue Chao, Dan Chen, Wenyan Hu, Rongzhen Luo, Jiehua He
    Modern Pathology.2020; 33(10): 1945.     CrossRef
  • Micropapillary pattern in pure mucinous carcinoma of the breast – does it matter or not?
    Xiaoli Xu, Rui Bi, Ruohong Shui, Baohua Yu, Yufan Cheng, Xiaoyu Tu, Wentao Yang
    Histopathology.2019; 74(2): 248.     CrossRef
  • An Update of Mucinous Lesions of the Breast
    Beth T. Harrison, Deborah A. Dillon
    Surgical Pathology Clinics.2018; 11(1): 61.     CrossRef
  • The clinicopathological significance of micropapillary pattern in colorectal cancers
    Jung-Soo Pyo, Mee Ja Park, Dong-Wook Kang
    Human Pathology.2018; 77: 159.     CrossRef
  • The sonographic findings of micropapillary pattern in pure mucinous carcinoma of the breast
    Heqing Zhang, Li Qiu, Yulan Peng
    World Journal of Surgical Oncology.2018;[Epub]     CrossRef
  • Diagnostic dilemma of micropapillary variant of mucinous breast cancer
    Geok Hoon Lim, Zhiyan Yan, Mihir Gudi
    BMJ Case Reports.2018; : bcr-2018-225775.     CrossRef
Case Studies
Mucinous Cystadenoma of the Testis: A Case Report with Immunohistochemical Findings
Gilhyang Kim, Dohee Kwon, Hee Young Na, Sehui Kim, Kyung Chul Moon
J Pathol Transl Med. 2017;51(2):180-184.   Published online February 13, 2017
DOI: https://doi.org/10.4132/jptm.2016.08.30
  • 8,060 View
  • 122 Download
  • 5 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Mucinous cystadenoma of the testis is a very rare tumor. Herein, we report a case of mucinous cystadenoma arising in the testis of a 61-year-old man, along with a literature review. Computed tomography showed a 2.5-cm-sized poorly enhancing cystic mass. Grossly, the tumor was a unilocular cystic mass filled with mucinous material and confined to the testicular parenchyma. Histologically, the cyst had a fibrotic wall lined by mucinous columnar epithelium without atypia. Immunohistochemical staining was positive for cytokeratin 20 and CDX2, as well as focally positive for cytokeratin 7. The pathologic diagnosis was mucinous cystadenoma.

Citations

Citations to this article as recorded by  
  • Review of Paratesticular Appendageal Tumors, Morphology, Immunohistochemistry, and Recent Molecular Advances
    Mathew Vega, Muhammad T. Idrees
    Surgical Pathology Clinics.2024;[Epub]     CrossRef
  • Cistoadenoma Mucinoso Paratesticular: Caso Interesante en el Instituto Guatemalteco de Seguridad Social
    Edgar Estuardo González López, Carlos Gonzalo Estrada Pazos
    Revista Guatemalteca de Urología.2023; 10(2): 16.     CrossRef
  • Primary borderline mucinous tumor of the testis with postoperative metastasis: A rare case report
    Yingyu Shi, Ling Song, Yan Luo
    Radiology Case Reports.2023; 18(9): 3203.     CrossRef
  • Case report: Misdiagnosis of primary mucinous cystadenoma of the testicle by ultrasound
    Linlin Zhang, Jianyuan Xuan, Manxi Li, Mei Zhang, Yu Song, Ziang Pan, Bo Fan, Lin Lu, Hongyan Zhou, Yang Li
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Primary Borderline Mucinous Testicular Tumor: A Case Report and Literature Review
    Changjuan Hao, Chunsong Kang, Xiaoyan Kang, Zhuanzhuan Yu, Tingting Li, Jiping Xue
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Ovarian-type Tumors (Mullerian Tumors) of the Testis: Clinicopathologic Findings with Recent Advances
    Michelle S Lin, Alberto G Ayala, Jae Y Ro
    annals of urologic oncology.2019; : 1.     CrossRef
  • Borderline Mucinous Testicular Tumour: Diagnostic and Management difficulties
    Krishan Pratap, Marlon Perera, Frances Malczewski, Rachel Esler
    BMJ Case Reports.2018; : bcr-2017-223787.     CrossRef
  • Mucinous tumor arising in a giant sacrococcygeal teratoma
    Fengtian Zhang, Xiaolong Yu, Jin Zeng, Min Dai
    Medicine.2017; 96(47): e8759.     CrossRef
Mucinous Carcinoma with Extensive Signet Ring Cell Differentiation: A Case Report
Hye Min Kim, Eun Kyung Kim, Ja Seung Koo
J Pathol Transl Med. 2017;51(2):176-179.   Published online December 5, 2016
DOI: https://doi.org/10.4132/jptm.2016.08.17
  • 9,605 View
  • 166 Download
  • 3 Web of Science
  • 3 Crossref
AbstractAbstract PDF
Breast cancers that present with mucin include mucinous carcinoma and carcinoma with signet ring cell differentiation. The former shows extracellular mucin and the latter shows abundant intracellular mucin. Here, we report a case of breast cancer showing both extracellular mucin and extensive signet ring cell differentiation due to abundant intracellular mucin. Unlike mucinous carcinoma, this case had the features of high-grade nuclear pleomorphism, high mitotic index, estrogen receptor negativity, progesterone receptor negativity, human epidermal growth factor receptor-2 positivity, and ductal type with positivity for E-cadherin. In a case with signet ring cell differentiation, differential diagnosis with metastatic signet ring cell carcinoma of the stomach and colon is essential. In this case, the presence of accompanied ductal carcinoma in situ component and mammaglobin and gross cystic disease fluid protein-15 positivity were findings that suggested the breast as the origin.

Citations

Citations to this article as recorded by  
  • Research on the Histological Features and Pathological Types of Gastric Adenocarcinoma With Mucinous Differentiation
    Nian-Long Meng, Yang-kun Wang, Hai-Li Wang, Jun-Ling Zhou, Su-nan Wang
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
    Yunjeong Jang, Hera Jung, Han-Na Kim, Youjeong Seo, Emad Alsharif, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Yeon Hee Park, Eun Yoon Cho, Soo Youn Cho
    Journal of Pathology and Translational Medicine.2020; 54(1): 95.     CrossRef
  • Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy
    Yunjeong Jang, Eun Yoon Cho, Soo Youn Cho
    Journal of Breast Cancer.2019; 22(2): 336.     CrossRef
Original Article
Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria
Soohyun Hwang, Joungho Han, Misun Choi, Myung-Ju Ahn, Yong Soo Choi
J Pathol Transl Med. 2017;51(1):56-68.   Published online October 16, 2016
DOI: https://doi.org/10.4132/jptm.2016.09.17
  • 9,533 View
  • 229 Download
  • 8 Web of Science
  • 7 Crossref
AbstractAbstract PDF
Background
We reviewed a series of 188 resected pulmonary mucinous adenocarcinomas (MAs) to clarify the prognostic significance of lepidic and non-lepidic patterns.
Methods
Non-lepidic patterns were divided into bland, non-distorted acini with uncertain invasiveness (pattern 1), unequivocal invasion into stroma (pattern 2), or invasion into alveolar spaces (pattern 3).
Results
The mean proportion of invasive patterns (patterns 2 and 3) was lowest in small (≤ 3 cm) tumors, and gradually increased in intermediate (> 3 cm and ≤ 7 cm) and large (> 7 cm) tumors (8.4%, 34.3%, and 50.1%, respectively). Adjusted T (aT) stage, as determined by the size of invasive patterns, was positively correlated with adverse histologic and clinical features including older age, male sex, and ever smokers. aTis tumors, which were exclusively composed of lepidic pattern (n = 9), or a mixture of lepidic and pattern 1 (n = 40) without any invasive patterns, showed 100% disease- free survival (DFS). The aT1mi tumors, with minimal (≤ 5 mm) invasive patterns (n = 63), showed a 95.2% 5-year DFS, with recurrences (n = 2) limited to tumors greater than 3 cm in total size (n = 23). Both T and aT stage were significantly associated with DFS; however, survival within the separate T-stage subgroups was stratified according to the aT stage, most notably in the intermediatestage subgroups. In multivariate analysis, the size of invasive patterns (p = .020), pleural invasion (p < .001), and vascular invasion (p = .048) were independent predictors of recurrence, whereas total size failed to achieve statistical significance (p = .121).
Conclusions
This study provides a rationale for histologic risk stratification in pulmonary MA based on the extent of invasive growth patterns with refined criteria for invasion.

Citations

Citations to this article as recorded by  
  • Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread
    Dong Woog Yoon, Soohyun Hwang, Tae Hee Hong, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Jong Ho Cho
    Annals of Surgical Oncology.2024; 31(1): 201.     CrossRef
  • Pulmonary invasive mucinous adenocarcinoma
    Wei‐Chin Chang, Yu Zhi Zhang, Andrew G Nicholson
    Histopathology.2024; 84(1): 18.     CrossRef
  • Micropapillary Pattern in Invasive Mucinous Adenocarcinoma of the Lung: Comparison With Invasive Non-Mucinous Adenocarcinoma
    Hui He, Lue Li, Yuan-yuan Wen, Li-yong Qian, Zhi-qiang Yang
    International Journal of Surgical Pathology.2024; 32(5): 926.     CrossRef
  • Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma
    Dae Hyeon Kim, So Young Bae, Kwon Joong Na, Samina Park, In Kyu Park, Chang Hyun Kang, Young Tae Kim
    Interactive CardioVascular and Thoracic Surgery.2022; 34(2): 229.     CrossRef
  • Micropapillary Pattern in Invasive Mucinous Adenocarcinoma of the Lung: Comparison with Invasive Non-Mucinous Adenocarcinoma
    Hui He, Yuanyuan Wen, Liyong Qian, Zhiqiang Yang
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung
    Tomonari Oki, Keiju Aokage, Shogo Nomura, Kenta Tane, Tomohiro Miyoshi, Norihiko Shiiya, Kazuhito Funai, Masahiro Tsuboi, Genichiro Ishii
    Journal of Cancer Research and Clinical Oncology.2020; 146(5): 1291.     CrossRef
  • Prognostic Impact of Histopathologic Features in Pulmonary Invasive Mucinous Adenocarcinomas
    Wei-Chin Chang, Yu Zhi Zhang, Eric Lim, Andrew G Nicholson
    American Journal of Clinical Pathology.2020; 154(1): 88.     CrossRef
Case Studies
A Pyloric Gland-Phenotype Ovarian Mucinous Tumor Resembling Lobular Endocervical Glandular Hyperplasia in a Patient with Peutz-Jeghers Syndrome
Eun Na Kim, Gu-Hwan Kim, Jiyoon Kim, In Ah Park, Jin Ho Shin, Yun Chai, Kyu-Rae Kim
J Pathol Transl Med. 2017;51(2):159-164.   Published online August 22, 2016
DOI: https://doi.org/10.4132/jptm.2016.07.01
  • 8,065 View
  • 206 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDF
We describe an ovarian mucinous neoplasm that histologically resembles lobular endocervical glandular hyperplasia (LEGH) containing pyloric gland type mucin in a patient with Peutz-Jeghers syndrome (PJS). Although ovarian mucinous tumors rarely occur in PJS patients, their pyloric gland phenotype has not been clearly determined. The histopathologic features of the ovarian mucinous tumor were reminiscent of LEGH. The cytoplasmic mucin was stained with periodic acid-Schiff reaction after diastase treatment but was negative for Alcian blue pH 2.5, suggesting the presence of neutral mucin. Immunohistochemically, the epithelium expressed various gastric markers, including MUC6, HIK1083, and carbonic anhydrase-IX. Multiple ligation-dependent probe amplification detected a germline heterozygous deletion mutation at exons 1–7 of the STK11 gene (c.1-?_920+?del) in peripheral blood leukocytes and mosaic loss of heterozygosity in ovarian tumor tissue. Considering that LEGH and/or gastric-type cervical adenocarcinoma can be found in patients with PJS carrying germline and/or somatic STK11 mutations, our case indicates that STK11 mutations have an important role in the proliferation of pyloric-phenotype mucinous epithelium at various anatomical locations.

Citations

Citations to this article as recorded by  
  • Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report
    Hiroshi Yoshida, Kengo Hiranuma, Mariko Nakahara, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Kouya Shiraishi, Mitsuya Ishikawa, Tomoyasu Kato
    International Journal of Surgical Pathology.2024; 32(2): 394.     CrossRef
  • Preoperative multimodal ultrasonic imaging in a case of Peutz-Jeghers syndrome complicated by atypical lobular endocervical glandular hyperplasia: a case report and literature review
    Liwen Yang, Duan Duan, Ying Xiong, Tianjiao Liu, Lijun Zhao, Fan Lai, Dingxian Gu, Liuying Zhou
    Hereditary Cancer in Clinical Practice.2024;[Epub]     CrossRef
  • Gastric‐type glandular lesions of the female genital tract excluding the cervix: emerging pathological entities
    Richard W‐C Wong, Karen L Talia, W Glenn McCluggage
    Histopathology.2024; 85(1): 20.     CrossRef
  • Gastric-phenotype Mucinous Carcinoma of the Fallopian Tube with Secondary Ovarian Involvement in a Woman with Peutz-Jeghers Syndrome: A Case Report
    Mónica Bronte Anaut, Javier Arredondo Montero, Maria Pilar Fernández Seara, Rosa Guarch Troyas
    International Journal of Surgical Pathology.2023; 31(1): 92.     CrossRef
  • Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing
    Swati Garg, Teddy S. Nagaria, Blaise Clarke, Orit Freedman, Zanobia Khan, Joerg Schwock, Marcus Q. Bernardini, Amit M. Oza, Kathy Han, Adam C. Smith, Tracy L. Stockley, Marjan Rouzbahman
    Modern Pathology.2019; 32(12): 1823.     CrossRef
  • The developing spectrum of gastric-type cervical glandular lesions
    Karen L. Talia, W. Glenn McCluggage
    Pathology.2018; 50(2): 122.     CrossRef
ThinPrep Cytological Findings of Desmoplastic Small Round Cell Tumor with Extensive Glandular Differentiation: A Case Study
Hyun-Jung Kim, Byeong Seok Sohn, Ji-Eun Kwon, Jeong Yeon Kim, Kyeongmee Park
Korean J Pathol. 2013;47(2):182-187.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.182
  • 6,354 View
  • 66 Download
  • 9 Crossref
AbstractAbstract PDF

Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive neoplasm. The cytological diagnosis of this tumor has only been reported in a few cases. In most of these cases, the diagnosis was made using fine-needle aspiration cytology. Most DSRCTs resemble disseminated carcinomatoses in their clinical manifestation as well as cytomorphologically, even in young-adult patients. These authors report a case of using peritoneal-washing and pleural-effusion ThinPrep cytology to diagnose DSRCT, with extensive glandular differentiation and mucin vacuoles. We found that fibrillary stromal fragment, clinical setting, and adjunctive immunocytochemical staining were most helpful for avoiding misdiagnosis.

Citations

Citations to this article as recorded by  
  • Desmoplastic Small Round Cell Tumor Involving Serous Fluid: Cytologic Features and Diagnostic Pitfalls: A Series of 8 Cases
    Nibras L Fakhri, Qiong Gan
    American Journal of Clinical Pathology.2023; 160(4): 417.     CrossRef
  • A Review of Effusion Cytomorphology of Small Round Cell Tumors
    Lucy M. Han, Christopher J. VandenBussche, Mads Abildtrup, Ashish Chandra, Poonam Vohra
    Acta Cytologica.2022; 66(4): 336.     CrossRef
  • Intra-abdominal desmoplastic small blue round cell tumor: A case report
    Tareq Hamed Al Taei, Hasan Al Fardan, Sarah Ali Al Mail
    Radiology Case Reports.2022; 17(12): 4502.     CrossRef
  • Desmoplastic Small Round Cell Tumor of the Kidney: Report of a Case, Literature Review, and Comprehensive Discussion of the Distinctive Morphologic, Immunohistochemical, and Molecular Features in the Differential Diagnosis of Small Round Cell Tumors Affec
    Carlos A. Galliani, Michele Bisceglia, Antonio Del Giudice, Giuseppe Cretì
    Advances in Anatomic Pathology.2020; 27(6): 408.     CrossRef
  • Intra-abdominal desmoplastic small round cell tumors: CT and FDG-PET/CT findings with histopathological association
    JINGJING CHEN, ZENGJIE WU, BINBIN SUN, DACHENG LI, ZHENGUANG WANG, FANGJUN LIU, HUI HUA
    Oncology Letters.2016; 11(5): 3298.     CrossRef
  • Desmoplastic small round cell tumor with sphere‐like clusters mimicking adenocarcinoma
    Yukinori Hattori, Akihiko Yoshida, Naoshi Sasaki, Yasuo Shibuki, Kenji Tamura, Koji Tsuta
    Diagnostic Cytopathology.2015; 43(3): 214.     CrossRef
  • Tumor intraabdominal desmoplásico de células pequeñas y redondas
    Andrés Alejandro Briseño-Hernández, Deissy Roxana Quezada-López, Lilia Edith Corona-Cobián, Agar Castañeda-Chávez, Alfonso Tonatiuh Duarte-Ojeda, Michel Dassaejv Macías-Amezcua
    Cirugía y Cirujanos.2015; 83(3): 243.     CrossRef
  • Intra-abdominal desmoplastic small round cell tumour
    Andrés Alejandro Briseño-Hernández, Deissy Roxana Quezada-López, Lilia Edith Corona-Cobián, Agar Castañeda-Chávez, Alfonso Tonatiuh Duarte-Ojeda, Michel Dassaejv Macías-Amezcua
    Cirugía y Cirujanos (English Edition).2015; 83(3): 243.     CrossRef
  • Diagnostic Pitfalls of Differentiating Desmoplastic Small Round Cell Tumor (DSRCT) From Wilms Tumor (WT)
    Michael A. Arnold, Lynn Schoenfield, Berkeley N. Limketkai, Christina A. Arnold
    American Journal of Surgical Pathology.2014; 38(9): 1220.     CrossRef
Original Article
Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes
Joo-Yeun Kim, Na Ri Shin, Ahrong Kim, Hyun-Jeong Lee, Won-young Park, Jee-Yeon Kim, Chang-Hun Lee, Gi-Young Huh, Do Youn Park
Korean J Pathol. 2013;47(1):28-35.   Published online February 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.1.28
  • 9,419 View
  • 119 Download
  • 68 Crossref
AbstractAbstract PDF
Background

Gastric cancers with microsatellite instabilities (MSI) have been reported to be associated with favorable prognosis. However, the significance of the effect of MSI on the clinicopathological features, as well as its association with mucin phenotype, remains unclear.

Methods

MSI status was assessed in 414 cases of gastric cancer using polymerase chain reaction analysis of five microsatellite loci, as recommended by National Cancer Institution criteria. The expression of mucins (MUC5AC, MUC6, MUC2, and CD10) was assessed.

Results

Out of 414 total cases of gastric cancer, 380 (91.7%), 11 (2.7%), and 23 (5.6%) were microsatellite stable (MSS), low-level MSI (MSI-L), and high-level MSI (MSI-H), respectively. Compared to MSS/MSI-L, MSI-H gastric cancers were associated with older age (p=0.010), tumor size (p=0.014), excavated gross (p=0.042), intestinal type (p=0.028), aggressive behaviors (increase of T stage [p=0.009]), perineural invasion [p=0.022], and lymphovascular emboli [p=0.027]). MSI-H gastric cancers were associated with tumor necrosis (p=0.041), tumor-infiltrating lymphocytes (≥2/high power field, p<0.001), expanding growth patterns (p=0.038), gastric predominant mucin phenotypes (p=0.028), and MUC6 expression (p=0.016). Tumor necrosis (≥10% of mass, p=0.031), tumor-infiltrating lymphocytes (p<0.001), intestinal type (p=0.014), and gastric mucin phenotypes (p=0.020) could represent independent features associated with MSI-H gastric cancers. MSI-H intestinal type gastric cancers had a tendency for poor prognosis in univariate analysis (p=0.054) but no association in Cox multivariate analysis (p=0.197).

Conclusions

Our data suggest that MSI-H gastric cancers exhibit distinct aggressive biologic behaviors and a gastric mucin phenotype. This contradicts previous reports that describe MSI-H gastric cancer as being associated with favorable prognosis.

Citations

Citations to this article as recorded by  
  • Non–Pure Intestinal Phenotype as an Indicator of Progression in Sporadic Nonampullary Duodenal Adenomas: A Multicenter Retrospective Cohort Study
    Ryotaro Uema, Yoshito Hayashi, Masato Komori, Narihiro Shibukawa, Noriko Hayashi, Masayoshi Horimoto, Takuya Yamada, Masashi Yamamoto, Satoshi Hiyama, Kazuo Kinoshita, Hideharu Ogiyama, Shinjiro Yamaguchi, Satoshi Egawa, Takashi Kanesaka, Minoru Kato, Shu
    Clinical and Translational Gastroenterology.2024; 15(1): e00649.     CrossRef
  • Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer
    Xingchi Chen, Zijian Zhuang, Lin Pen, Jing Xue, Haitao Zhu, Lirong Zhang, Dongqing Wang
    Abdominal Radiology.2024; 49(5): 1363.     CrossRef
  • The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review
    J. Bos, T.S. Groen-van Schooten, C.P. Brugman, F.S. Jamaludin, H.W.M. van Laarhoven, S. Derks
    Cancer Treatment Reviews.2024; 127: 102737.     CrossRef
  • Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair
    Akira Ooki, Hiroki Osumi, Koichiro Yoshino, Kensei Yamaguchi
    Gastric Cancer.2024; 27(5): 907.     CrossRef
  • The mechanism of RGS5 regulating gastric cancer mismatch repair protein
    Zhenwei Yang, Ranran Zhang, Jialong Liu, Sufang Tian, Hailin Zhang, Lingxiu Zeng, Yangyang Zhang, Liping Gao, Meng Wang, Wenqing Shan, Jing Liu
    Molecular Carcinogenesis.2024; 63(9): 1750.     CrossRef
  • Prognostic significance of microsatellite instability in patients with resectable gastric cancer
    Marina Alessandra Pereira, Marcus Fernando Kodama Pertille Ramos, Leonardo Cardili, André Roncon Dias, Venancio Avancini Ferreira Alves, Evandro Sobroza de Mello, Ulysses Ribeiro
    Journal of Gastrointestinal Surgery.2024; 28(10): 1687.     CrossRef
  • Access to radiotherapy in improving gastric cancer care quality and equality
    Minmin Wang, Kepei Huang, Xiaohan Fan, Jia Wang, Yinzi Jin, Zhi-Jie Zheng
    Communications Medicine.2024;[Epub]     CrossRef
  • Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer
    Sung Hak Lee, Yujin Lee, Hyun‐Jong Jang
    International Journal of Cancer.2023; 152(2): 298.     CrossRef
  • Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
    Yasushi Sato, Koichi Okamoto, Yutaka Kawano, Akinari Kasai, Tomoyuki Kawaguchi, Tamotsu Sagawa, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama
    Journal of Clinical Medicine.2023; 12(14): 4646.     CrossRef
  • The results of treatment for resectable gastric cancer with microsatellite instability
    H. Sun, S. N. Nered, A. A. Tryakin, E. V. Artamonova, A. E. Kalinin, V. E. Bugaev, A. M. Stroganova, N. S. Besova, P. P. Arkhiri, V. I. Marshall, R. Sh. Abdulaeva, I. S. Stilidi
    Pelvic Surgery and Oncology.2023; 13(2): 17.     CrossRef
  • Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
    Hui Wu, Wenyuan Ma, Congfa Jiang, Ning Li, Xin Xu, Yongfeng Ding, Haiping Jiang
    Annals of Surgical Oncology.2023; 30(13): 8572.     CrossRef
  • Dual-layer spectral-detector CT for predicting microsatellite instability status and prognosis in locally advanced gastric cancer
    Yongjian Zhu, Peng Wang, Bingzhi Wang, Zhichao Jiang, Ying Li, Jun Jiang, Yuxin Zhong, Liyan Xue, Liming Jiang
    Insights into Imaging.2023;[Epub]     CrossRef
  • Concordance between microsatellite instability testing and immunohistochemistry for mismatch repair proteins and efficient screening of mismatch repair deficient gastric cancer
    Gou Yamamoto, Tetsuya Ito, Okihide Suzuki, Nao Kamae, Miho Kakuta, Akemi Takahashi, Katsuya Iuchi, Tomio Arai, Hideyuki Ishida, Kiwamu Akagi
    Oncology Letters.2023;[Epub]     CrossRef
  • Low incidence of microsatellite instability in gastric cancers and its association with the clinicopathological characteristics: a comparative study
    Fateme Fooladi Talari, Ali Bozorg, Sirous Zeinali, Mohammadreza Zali, Zhale Mohsenifar, Hamid Asadzadeh Aghdaei, Kaveh Baghaei
    Scientific Reports.2023;[Epub]     CrossRef
  • Mutational separation and clinical outcomes of TP53 and CDH1 in gastric cancer
    He-Li Liu, Huan Peng, Chang-Hao Huang, Hai-Yan Zhou, Jie Ge
    World Journal of Gastrointestinal Surgery.2023; 15(12): 2855.     CrossRef
  • Genomic and Immunologic Markers of Intrinsic Resistance to Pembrolizumab Monotherapy in Microsatellite Instability-High Gastric Cancer: Observations from a Prospective Phase II Study
    Haibo Qiu
    Global Medical Genetics.2022; 09(02): 060.     CrossRef
  • Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan
    Tsutomu Yoshida, Go Ogura, Mikiko Tanabe, Takuo Hayashi, Chiho Ohbayashi, Mizutomo Azuma, Chikara Kunisaki, Yoichi Akazawa, Soji Ozawa, Sohei Matsumoto, Takayoshi Suzuki, Akira Mitoro, Tetsu Fukunaga, Akiko Shimizu, Go Fujimoto, Takashi Yao
    Cancer Biology & Therapy.2022; 23(1): 191.     CrossRef
  • Development of Tissue-Agnostic Treatments for Patients with Cancer
    Steven Lemery, Lola Fashoyin-Aje, Leigh Marcus, Sandra Casak, Julie Schneider, Marc Theoret, Paul Kluetz, Richard Pazdur, Julia A. Beaver
    Annual Review of Cancer Biology.2022; 6(1): 147.     CrossRef
  • A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics
    Xiuqun Liang, Yinbo Wu, Ying Liu, Danping Yu, Chencui Huang, Zhi Li
    Abdominal Radiology.2022; 47(6): 2036.     CrossRef
  • Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
    Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li
    Journal for ImmunoTherapy of Cancer.2022; 10(6): e004703.     CrossRef
  • Eldest gastric cancer patient with high microsatellite instability responding to pembrolizumab
    Akinobu Wakasugi, Akinori Sasaki, Risa Okamoto, Yasuaki Motomura
    International Cancer Conference Journal.2022; 12(1): 59.     CrossRef
  • Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer
    Xiao-Li Wei, Jian-Ying Xu, De-Shen Wang, Dong-Liang Chen, Chao Ren, Jia-Ning Li, Feng Wang, Feng-Hua Wang, Rui-Hua Xu
    Therapeutic Advances in Medical Oncology.2021;[Epub]     CrossRef
  • Clinical and morphological portrait of tumors with microsatellite instability
    A. A. Musaelyan, V. D. Nazarov, A. S. Budnikova, S. V. Lapin, S. L. Vorobyev, V. L. Emanuel, A. A. Zakharenko, S. V. Orlov
    Advances in Molecular Oncology.2021; 8(2): 52.     CrossRef
  • How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches
    Michele Ghidini, Angelica Petrillo, Andrea Botticelli, Dario Trapani, Alessandro Parisi, Anna La Salvia, Elham Sajjadi, Roberto Piciotti, Nicola Fusco, Shelize Khakoo
    Journal of Clinical Medicine.2021; 10(7): 1412.     CrossRef
  • Microsatellite instability in Gastric Cancer: Between lights and shadows
    Elisabetta Puliga, Simona Corso, Filippo Pietrantonio, Silvia Giordano
    Cancer Treatment Reviews.2021; 95: 102175.     CrossRef
  • Impact of microsatellite status on negative lymph node count and prognostic relevance after curative gastrectomy
    Zhenghao Cai, Junjun Ma, Shuchun Li, Abe Fingerhut, Jing Sun, Lu Zang, Chao Yan, Wentao Liu, Zhenggang Zhu, Minhua Zheng
    Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer
    Zhenghao Cai, Haiqin Song, Abe Fingerhut, Jing Sun, Junjun Ma, Luyang Zhang, Shuchun Li, Chaoran Yu, Minhua Zheng, Lu Zang
    BMC Cancer.2021;[Epub]     CrossRef
  • Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability–High Gastric Cancer
    Minsuk Kwon, Minae An, Samuel J. Klempner, Hyuk Lee, Kyoung-Mee Kim, Jason K. Sa, Hee Jin Cho, Jung Yong Hong, Taehyang Lee, Yang Won Min, Tae Jun Kim, Byung-Hoon Min, Woong-Yang Park, Won Ki Kang, Kyu-Tae Kim, Seung Tae Kim, Jeeyun Lee
    Cancer Discovery.2021; 11(9): 2168.     CrossRef
  • Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article
    Alexander R. Siebenhüner, Sara De Dosso, Daniel Helbling, Christoforos Astaras, Petr Szturz, Peter Moosmann, Stefanie Pederiva, Thomas Winder, Philippe Von Burg, Markus Borner
    Oncology Research and Treatment.2021; 44(9): 485.     CrossRef
  • High homogeneity of mismatch repair deficiency in advanced prostate cancer
    Christoph Fraune, Ronald Simon, Doris Höflmayer, Katharina Möller, David Dum, Franziska Büscheck, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Andrea Hinsch, Eike Burandt, Till Sebastian Clauditz, Waldemar Wilczak, Guido Sauter, Stefan Steu
    Virchows Archiv.2020; 476(5): 745.     CrossRef
  • High homogeneity of MMR deficiency in ovarian cancer
    Christoph Fraune, Janina Rosebrock, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Barbara Schmalfeldt, Volkmar Müller, Linn Wölber, Isabell Witzel, Peter Paluchowski, Christian Wilke, Uwe He
    Gynecologic Oncology.2020; 156(3): 669.     CrossRef
  • Molecular Classification of Gastric Cancer among Alaska Native People
    Holly Martinson, Dominic Mallari, Christine Richter, Tsung-Teh Wu, James Tiesinga, Steven Alberts, Matthew Olnes
    Cancers.2020; 12(1): 198.     CrossRef
  • Tumor immune response and immunotherapy in gastric cancer
    Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
    Journal of Pathology and Translational Medicine.2020; 54(1): 20.     CrossRef
  • MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass
    Christoph Fraune, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Christian Kähler, Martina Kluth, Doris Höflmayer, Franziska Büscheck, David Dum, Andreas M. Luebke, Eike Burandt, Till Sebastian Clauditz, Waldemar Wilczak, Guido Sauter, Stefan
    Urologic Oncology: Seminars and Original Investigations.2020; 38(5): 488.     CrossRef
  • MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes
    Christoph Fraune, Eike Burandt, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Franziska Büscheck, Doris Höflmayer, Niclas Ch. Blessin, Tim Mandelkow, Wenchao Li, Daniel Perez, Jakob R. Izbicki, Waldemar Wilczak, Guido Sauter, J
    Annals of Surgical Oncology.2020; 27(10): 3997.     CrossRef
  • CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
    Jerry B. Harvey, Luan H. Phan, Oscar E. Villarreal, Jessica L. Bowser
    Frontiers in Immunology.2020;[Epub]     CrossRef
  • Tumor copy-number alterations predict response to immune-checkpoint-blockade in gastrointestinal cancer
    Zhihao Lu, Huan Chen, Shuang Li, Jifang Gong, Jian Li, Jianling Zou, Lihong Wu, Jianing Yu, Wenbo Han, Huaibo Sun, Xi Jiao, Xiaotian Zhang, Zhi Peng, Ming Lu, Zhenghang Wang, Henghui Zhang, Lin Shen
    Journal for ImmunoTherapy of Cancer.2020; 8(2): e000374.     CrossRef
  • Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray
    Chong Zhao, Zhiqiang Feng, Hongzhen He, Dan Zang, Hong Du, Hongli Huang, Yanlei Du, Jie He, Yongjian Zhou, Yuqiang Nie, Girijesh Kumar Patel
    PLOS ONE.2020; 15(10): e0238836.     CrossRef
  • Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects
    Jooyoung Lee, Su Jin Chung, Ji Min Choi, Yoo Min Han, Joo Sung Kim, Greger Lindberg
    Gastroenterology Research and Practice.2020; 2020: 1.     CrossRef
  • Implication of expression of MMR proteins and clinicopathological characteristics in gastric cancer
    Renu Verma, Puja Sakhuja, Ritu Srivastava, Prakash Chand Sharma
    Asia-Pacific Journal of Oncology.2020; : 1.     CrossRef
  • Prognostic significance of microsatellite‐instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy
    Georg Martin Haag, Elena Czink, Aysel Ahadova, Thomas Schmidt, Leila Sisic, Susanne Blank, Ulrike Heger, Leonidas Apostolidis, Anne Katrin Berger, Christoph Springfeld, Felix Lasitschka, Dirk Jäger, Magnus von Knebel Doeberitz, Matthias Kloor
    International Journal of Cancer.2019; 144(7): 1697.     CrossRef
  • Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer
    Zhihao Lu, Jianling Zou, Ying Hu, Shuang Li, Tao Zhou, Jifang Gong, Jian Li, Xiaotian Zhang, Jun Zhou, Ming Lu, Xicheng Wang, Zhi Peng, Changsong Qi, Yanyan Li, Jie Li, Yan Li, Jianyin Zou, Xiao Du, Henghui Zhang, Lin Shen
    JAMA Network Open.2019; 2(7): e197621.     CrossRef
  • Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
    Carolina Martinez-Ciarpaglini, Tania Fleitas-Kanonnikoff, Valentina Gambardella, Marta Llorca, Cristina Mongort, Regina Mengual, Gema Nieto, Lara Navarro, Marisol Huerta, Susana Rosello, Desamparados Roda, Noelia Tarazona, Samuel Navarro, Gloria Ribas, An
    ESMO Open.2019; 4(3): e000470.     CrossRef
  • The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma
    Gagandeep Brar, Manish A. Shah
    Therapeutic Advances in Gastroenterology.2019;[Epub]     CrossRef
  • Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
    Alessandro Cavaliere, Valeria Merz, Simona Casalino, Camilla Zecchetto, Francesca Simionato, Hayley Louise Salt, Serena Contarelli, Raffaela Santoro, Davide Melisi
    Journal of Gastric Cancer.2019; 19(4): 375.     CrossRef
  • MICROSATELLITE INSTABILITY AND GASTRIC CARCINOMA. REVIEW OF THELITERATURE
    D. L. Rotin, O. V. Paklina, I. O. Tin’kova, D. N. Grekov
    Russian Journal of Biotherapy.2019; 18(4): 17.     CrossRef
  • Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
    K Polom, L Marano, D Marrelli, R De Luca, G Roviello, V Savelli, P Tan, F Roviello
    Journal of British Surgery.2018; 105(3): 159.     CrossRef
  • Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes
    Chae H Kwon, Young K Kim, Sojeong Lee, Ahrong Kim, Hye J Park, Yuri Choi, Yeo J Won, Do Y Park, Gregory Y Lauwers
    Histopathology.2018; 72(4): 556.     CrossRef
  • Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches
    Margherita Ratti, Andrea Lampis, Jens C. Hahne, Rodolfo Passalacqua, Nicola Valeri
    Cellular and Molecular Life Sciences.2018; 75(22): 4151.     CrossRef
  • High-throughput Protein and mRNA Expression–based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications
    Sangjeong Ahn, So-Jeong Lee, Yonugkeum Kim, Ahrong Kim, Nari Shin, Kyung Un Choi, Chang-Hun Lee, Gi Yeong Huh, Kyong-Mee Kim, Namrata Setia, Gregory Y. Lauwers, Do Youn Park
    American Journal of Surgical Pathology.2017; 41(1): 106.     CrossRef
  • Molecular Testing for Gastrointestinal Cancer
    Hye Seung Lee, Woo Ho Kim, Yoonjin Kwak, Jiwon Koh, Jeong Mo Bae, Kyoung-Mee Kim, Mee Soo Chang, Hye Seung Han, Joon Mee Kim, Hwal Woong Kim, Hee Kyung Chang, Young Hee Choi, Ji Y. Park, Mi Jin Gu, Min Jin Lhee, Jung Yeon Kim, Hee Sung Kim, Mee-Yon Cho
    Journal of Pathology and Translational Medicine.2017; 51(2): 103.     CrossRef
  • Molecular testing of gastrointestinal tumours
    Matthew Evans, Matthew Smith, Brendan O'Sullivan, Philippe Taniere
    Diagnostic Histopathology.2017; 23(10): 442.     CrossRef
  • Gastric Carcinomas With Lymphoid Stroma
    Raul S Gonzalez, Justin M M Cates, Frank Revetta, Loralee A McMahon, Kay Washington
    American Journal of Clinical Pathology.2017; 148(6): 477.     CrossRef
  • Meta-Analysis of Prognostic Role of Ki-67 Labeling Index in Gastric Carcinoma
    Jung-Soo Pyo, Nae Yu Kim
    The International Journal of Biological Markers.2017; 32(4): 447.     CrossRef
  • Tissue-Agnostic Drug Development
    Keith T. Flaherty, Dung T. Le, Steven Lemery
    American Society of Clinical Oncology Educational Book.2017; (37): 222.     CrossRef
  • Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
    Mi Jung Kwon, Kab-Choong Kim, Eun Sook Nam, Seong Jin Cho, Hye-Rim Park, Soo Kee Min, Jinwon Seo, Ji-Young Choe, Hye Kyung Lee, Ho Suk Kang, Kyueng-Whan Min
    Oncotarget.2017; 8(47): 82399.     CrossRef
  • Hypermutation and microsatellite instability in gastrointestinal cancers
    Kizuki Yuza, Masayuki Nagahashi, Satoshi Watanabe, Kazuaki Takabe, Toshifumi Wakai
    Oncotarget.2017; 8(67): 112103.     CrossRef
  • The Emerging Role of Immunotherapy in Gastric and Esophageal Adenocarcinoma
    Bruno Bockorny, Eirini Pectasides
    Future Oncology.2016; 12(15): 1833.     CrossRef
  • Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland
    Katarzyna Karpińska-Kaczmarczyk, Magdalena Lewandowska, Małgorzata Ławniczak, Andrzej Białek, Elżbieta Urasińska
    Medical Science Monitor.2016; 22: 2886.     CrossRef
  • Immunotherapy for Gastroesophageal Cancer
    Emily Goode, Elizabeth Smyth
    Journal of Clinical Medicine.2016; 5(10): 84.     CrossRef
  • Lauren classification and individualized chemotherapy in gastric cancer
    JUNLI MA, HONG SHEN, LINDA KAPESA, SHAN ZENG
    Oncology Letters.2016; 11(5): 2959.     CrossRef
  • High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability
    Karol Polom, Daniele Marrelli, Valeria Pascale, Giandomenico Roviello, Costantino Voglino, Henry Rho, Carla Vindigni, Mario Marini, Raffaele Macchiarelli, Franco Roviello
    Journal of Cancer Research and Clinical Oncology.2016; 142(8): 1817.     CrossRef
  • MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis
    Jung-Soo Pyo, Jin Hee Sohn, Guhyun Kang, Dong-Hoon Kim, Kyungeun Kim, In-Gu Do, Dong Hyun Kim
    Journal of Pathology and Translational Medicine.2015; 49(3): 249.     CrossRef
  • Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma
    Jiwoon Choi, Soo Kyung Nam, Do Joong Park, Hwal Woong Kim, Hyung-Ho Kim, Woo Ho Kim, Hye Seung Lee
    APMIS.2015; 123(3): 215.     CrossRef
  • Clinicopathologic and molecular features associated with patient age in gastric cancer
    Ji Yeon Seo, Eun Hyo Jin, Hyun Jin Jo, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Hyun Chae Jung, Dong Ho Lee
    World Journal of Gastroenterology.2015; 21(22): 6905.     CrossRef
  • Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy
    Ismael Riquelme, Kathleen Saavedra, Jaime A. Espinoza, Helga Weber, Patricia García, Bruno Nervi, Marcelo Garrido, Alejandro H. Corvalán, Juan Carlos Roa, Carolina Bizama
    Oncotarget.2015; 6(28): 24750.     CrossRef
  • A phylogenetic model for understanding the effect of gene duplication on cancer progression
    Qin Ma, Jaxk H. Reeves, David A. Liberles, Lili Yu, Zheng Chang, Jing Zhao, Juan Cui, Ying Xu, Liang Liu
    Nucleic Acids Research.2014; 42(5): 2870.     CrossRef
  • The analysis of microsatellite instability in extracolonic gastrointestinal malignancy
    Andrew S. Williams, Weei-Yuarn Huang
    Pathology.2013; 45(6): 540.     CrossRef
Case Reports
Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma
Sung Eun Kim, Ji Hye Park, SoonWon Hong, Ja Seung Koo, Joon Jeong, Woo-Hee Jung
Korean J Pathol. 2012;46(6):611-616.   Published online December 26, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.6.611
  • 7,686 View
  • 57 Download
  • 13 Crossref
AbstractAbstract PDF

Mucinous cystadenocarcinoma (MCA) in the breast is a rare neoplasm. There have been 13 cases of primary breast MCA reported. The MCA presents as a large, partially cystic mass in postmenopausal woman with a good prognosis. The microscopic findings resemble those of ovarian, pancreatic, or appendiceal MCA. The aspiration findings showed mucin-containing cell clusters in the background of mucin and necrotic material. The cell clusters had intracytoplasmic mucin displacing atypical nuclei to the periphery. Histologically, the tumor revealed an abundant mucin pool with small floating clusters of mucin-containing tumor cells. There were also small cysts lined by a single layer of tall columnar mucinous cells, resembling those of the uterine endocervix. The cancer cells were positive for mucin (MUC) 5 and negative for MUC2 and MUC6. This mucin profile is different from ordinary mucinous carcinoma and may be a unique characteristic of breast MCA.

Citations

Citations to this article as recorded by  
  • Mucinous cystadenocarcinoma of the breast harbours TRPS1 expressions and PIK3CA alterations
    Wei‐Yu Chen, Yu‐Hsuan Hu, Yu‐Hsin Tsai, Jen‐Fan Hang, Puay Hoon Tan, Chih‐Jung Chen
    Histopathology.2024; 84(3): 550.     CrossRef
  • Pure mucinous adenocarcinoma of the breast with the rare lymphoplasmacytic infiltration: A case report with review of literature
    Yash Hasmukhbhai Prajapati, Vishal Bhabhor, Kahan Samirkumar Mehta, Mithoon Barot, Husen Boriwala, Mohamed Omar
    Clinical Case Reports.2024;[Epub]     CrossRef
  • HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature
    Ismail Guzelis, Betul Bolat Kucukzeybek, Mehmet Ali Uyaroglu, Melek Bekler Gokova, Gulten Sezgin, Yuksel Kucukzeybek
    Diagnostic Cytopathology.2024;[Epub]     CrossRef
  • Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
    Ting Lei, Yong Qiang Shi, Tong Bing Chen
    Diagnostic Pathology.2023;[Epub]     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association
    Federica Vegni, Nicoletta D’Alessandris, Angela Santoro, Giuseppe Angelico, Giulia Scaglione, Angela Carlino, Damiano Arciuolo, Michele Valente, Stefania Sfregola, Maria Natale, Alejandro Martin Sanchez, Valeria Masciullo, Gian Franco Zannoni, Antonino Mu
    Journal of Personalized Medicine.2023; 13(6): 948.     CrossRef
  • Special Histologic Type and Rare Breast Tumors – Diagnostic Review and Clinico-Pathological Implications
    Benjamin Yongcheng Tan, Elaine Hsuen Lim, Puay Hoon Tan
    Surgical Pathology Clinics.2022; 15(1): 29.     CrossRef
  • Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials—a case report
    Kanwalpreet Kaur, Ashini Shah, Jahnvi Gandhi, Priti Trivedi
    Journal of the Egyptian National Cancer Institute.2022;[Epub]     CrossRef
  • Mucinous carcinoma of the breast: distinctive histopathologic and genetic characteristics
    Minjung Jung
    Kosin Medical Journal.2022; 37(3): 176.     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast: A Rare Case Report With Review of Literature
    Ekta Jain, Abhishek Kumar, Raajul Jain, Shivani Sharma
    International Journal of Surgical Pathology.2021; 29(7): 740.     CrossRef
  • Mucinous Cystadenocarcinoma of the Breast: Report of 2 Cases Including One With Long-Term Local Recurrence
    Anupma Nayak, Ira J. Bleiweiss, Kimberly Dumoff, Tawfiqul A. Bhuiya
    International Journal of Surgical Pathology.2018; 26(8): 749.     CrossRef
  • Mucinous breast carcinoma with tall columnar cells
    N Tsoukalas, M Kiakou, M Tolia, ID Kostakis, M Galanopoulos, G Nakos, D Tryfonopoulos, G Kyrgias, G Koumakis
    The Annals of The Royal College of Surgeons of England.2018; 100(5): e132.     CrossRef
  • Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
    Minjung Seong, Eun Young Ko, Boo-Kyung Han, Soo Youn Cho, Eun Yoon Cho, Se Kyung Lee, Jeong Eon Lee
    Journal of Breast Cancer.2016; 19(3): 330.     CrossRef
  • Primary Mucinous Cystadenocarcinoma of the Breast with Endocervical-Like Mucinous Epithelium
    Dong-Liang Lin, Ji-Lin Hu, Shi-Hong Shao, Dong-Mei Sun, Ji-Gang Wang
    Breast Care.2013; 8(6): 445.     CrossRef
Primary Thymic Mucinous Adenocarcinoma: A Case Report
Jamshid Abdul-Ghafar, Suk-Joong Yong, Woocheol Kwon, Il Hwan Park, Soon-Hee Jung
Korean J Pathol. 2012;46(4):377-381.   Published online August 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.4.377
  • 7,810 View
  • 75 Download
  • 19 Crossref
AbstractAbstract PDF

Primary thymic mucinous adenocarcinoma is an extremely rare aggressive subtype of thymic carcinoma. With a review of literatures, only nine cases have been reported up to present. A 36-year-old woman was admitted for further evaluation and treatment of a mediastinal mass. The patient had no medical history of cancer. The clinicoradiological examination disclosed no tumor elsewhere. After the surgical excision of mediastinal mass, it was grossly a round semi-solid mass with mucin-filled cystic areas. Microscopically solid areas showed cords, small nests and dilated glands infiltrating the fibrotic parenchyma, while the cystic areas were lined by mucinous epithelium with tumor cells floating in extracellular-mucin pools. Some cystic walls underwent malignant transformation of the benign thymic epithelium. Immunohistochemically, the tumor cells were positive for cytokeratin (CK) 7, CK20, CD5, and CDX-2, and negative for thyroid transcription factor-1. In conclusion, the mucinous thymic adenocarcinoma should be recognized as a separate histopathological entity and considered in the differential diagnosis of mediastinal carcinomas.

Citations

Citations to this article as recorded by  
  • Primary mucinous adenocarcinoma of the thymus
    Kohei Soejima, Hidehito Matsuoka
    The Journal of the Japanese Association for Chest Surgery.2024; 38(6): 545.     CrossRef
  • Stage IV thymic mucinous adenocarcinoma under long-term disease control after primary tumor resection: A case report
    Chihaya Maeda, Tomoyuki Hishida, Kyohei Masai, Keisuke Asakura, Katsura Emoto, Hisao Asamura
    The Journal of the Japanese Association for Chest Surgery.2022; 36(2): 156.     CrossRef
  • Lenvatinib-refractory thymic mucinous carcinoma with PIK3CA mutation
    Akihiro Tsukaguchi, Shoichi Ihara, Hironao Yasuoka, Seigo Minami
    International Cancer Conference Journal.2022; 12(1): 36.     CrossRef
  • Thymic mucinous adenocarcinoma: A case report
    Hideki Tsubouchi, Naoki Ozeki, Yuka Suzuki, Koji Kawaguchi, Takayuki Fukui, Toyofumi F. Chen-Yoshikawa
    The Journal of the Japanese Association for Chest Surgery.2021; 35(5): 547.     CrossRef
  • Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report
    Man Li, Xiao-Yu Pu, Li-Hua Dong, Peng-Yu Chang
    World Journal of Clinical Cases.2021; 9(7): 1676.     CrossRef
  • Primary Mucinous Adenocarcinoma of the Thymus: a Rare Type of Thymic Carcinoma—Case Report
    Koichi Tomoshige, Tomoshi Tsuchiya, Keitaro Matsumoto, Takuro Miyazaki, Ryoichiro Doi, Ryusuke Machino, Satoshi Mizoguchi, Takamune Matumoto, Yutaka Maeda, Takeshi Nagayasu
    SN Comprehensive Clinical Medicine.2021; 3(5): 1233.     CrossRef
  • Primary mucinous adenocarcinoma of the thymus: A case report
    Tomoka Hamahiro, Ryo Maeda, Takanori Ayabe, Yuichiro Sato, Masaki Tomita
    Respiratory Medicine Case Reports.2021; 34: 101497.     CrossRef
  • Primary Thymic Mucinous Adenocarcinoma: A Case Report Focusing on Radiological Findings and Review of the Literature
    Young Hoon Koo, Jae Wook Lee, Jai Soung Park, Kyung Eun Shin, Heon Lee, Susie Chin
    Iranian Journal of Radiology.2020;[Epub]     CrossRef
  • Mucinous adenocarcinoma of the thymus: report of a case
    Fumihiko Kinoshita, Fumihiro Shoji, Kazuki Takada, Gouji Toyokawa, Tatsuro Okamoto, Tokujiro Yano, Yoshinao Oda, Yoshihiko Maehara
    General Thoracic and Cardiovascular Surgery.2018; 66(2): 111.     CrossRef
  • Thymic enteric type adenocarcinoma: A case report with cytological features
    Marie Tamai, Mitsuaki Ishida, Yusuke Ebisu, Hisashi Okamoto, Chika Miyasaka, Chisato Ohe, Yoshiko Uemura, Tomohito Saito, Tomohiro Murakawa, Koji Tsuta
    Diagnostic Cytopathology.2018; 46(1): 92.     CrossRef
  • Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation
    Neda Kalhor, Cesar A. Moran
    Human Pathology.2018; 74: 73.     CrossRef
  • Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature
    Ah-Young Kwon, Joungho Han, Jinah Chu, Yong Soo Choi, Byeong-Ho Jeong, Myung-Ju Ahn, Yong Chan Ahn
    Pathology - Research and Practice.2017; 213(2): 106.     CrossRef
  • Cytologic Characteristics of Thymic Adenocarcinoma with Enteric Differentiation: A Study of Four Fine-Needle Aspiration Specimens
    Ah-Young Kwon, Joungho Han, Hae-yon Cho, Seokhwi Kim, Heejin Bang, Jiyeon Hyeon
    Journal of Pathology and Translational Medicine.2017; 51(5): 509.     CrossRef
  • Mucinous cystic tumor with CK20 and CDX2 expression of the thymus: Is this a benign counterpart of adenocarcinoma of the thymus, enteric type?
    Jun Akiba, Hiroshi Harada, Shintaro Yokoyama, Toshihiro Hashiguchi, Akihiko Kawahara, Masahiro Mitsuoka, Shinzo Takamori, Hirohisa Yano
    Pathology International.2016; 66(1): 29.     CrossRef
  • Colon cancer chemotherapy for a patient with CDX2-expressing metastatic thymic adenocarcinoma: a case report and literature review
    Akihiko Sawaki, Mikiya Ishihara, Yuji Kozuka, Hiroyasu Oda, Satoshi Tamaru, Yumiko Sugawara, Yoshiki Yamashita, Toshiro Mizuno, Taizo Shiraishi, Naoyuki Katayama
    International Cancer Conference Journal.2016; 5(2): 113.     CrossRef
  • Adenocarcinoma of the Thymus, Enteric Type
    Bernhard Moser, Ana Iris Schiefer, Stefan Janik, Alexander Marx, Helmut Prosch, Wolfgang Pohl, Barbara Neudert, Anke Scharrer, Walter Klepetko, Leonhard Müllauer
    American Journal of Surgical Pathology.2015; 39(4): 541.     CrossRef
  • A Rare Case of Primary Thymic Adenocarcinoma Mimicking Small Cell Lung Cancer
    Eun Na Cho, Hye Sung Park, Tae Hoon Kim, Min Kwang Byun, Hyung Jung Kim, Chul Min Ahn, Yoon Soo Chang
    Tuberculosis and Respiratory Diseases.2015; 78(2): 112.     CrossRef
  • A Rare Case of Primary Tubular Adenocarcinoma of the Thymus, Enteric Immunophenotype: A Case Study and Review of the Literature
    Hae Yoen Jung, Hyundeuk Cho, Jin-Haeng Chung, Sang Byoung Bae, Ji-Hye Lee, Hyun Ju Lee, Si-Hyong Jang, Mee-Hye Oh
    Journal of Pathology and Translational Medicine.2015; 49(4): 331.     CrossRef
  • Primary mucinous adenocarcinoma of the thymus: a case report
    Tadashi Sakane, Kotaro Mizuno, Risa Oda, Takuya Matsui, Makoto Ito, Takeshi Yamada
    The Journal of the Japanese Association for Chest Surgery.2014; 28(7): 904.     CrossRef
Urachal Mucinous Tumor of Uncertain Malignant Potential: A Case Report
Jung-Woo Choi, Ju-Han Lee, Young-Sik Kim
Korean J Pathol. 2012;46(1):83-86.   Published online February 23, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.1.83
  • 9,005 View
  • 59 Download
  • 7 Crossref
AbstractAbstract PDF

Urachal mucinous tumor of uncertain malignant potential is very rare and is characterized by a multilocular cyst showing the proliferation of atypical mucin-secreting cells without stromal invasion. As in ovarian and appendiceal borderline tumors, it represents a transitional stage of mucinous carcinogenesis in the urachus. In addition, this tumor may recur locally and develop into pseudomyxoma peritonei. Due to its scarcity and diagnostic challenges, we report a mucinous tumor of uncertain malignant potential arising in the urachus.

Citations

Citations to this article as recorded by  
  • Mucinous Cystadenoma of the Urachus and Review of Current Classification of Urachal Mucinous Cystic Neoplasms
    Diping Wang, Norbert Sule
    Archives of Pathology & Laboratory Medicine.2019; 143(2): 258.     CrossRef
  • Urachal Mucinous Cystic Tumor of Low Malignant Potential with Concurrent Sigmoid Colon Adenocarcinoma
    Kelly Brennan, Paul Johnson, Heather Curtis, Thomas Arnason
    Case Reports in Gastrointestinal Medicine.2019; 2019: 1.     CrossRef
  • Pseudomyxoma Peritonei Arising from Mucinous Cystadenoma of the Urachus with Postoperative Disease-Free Survival over 15 Years
    Tomoki Kobayashi, Shinichi Mizuno, Hideki Matsuba, Min Kanamori, Toshio Tamauchi, Makoto Urano
    The Japanese Journal of Gastroenterological Surgery.2019; 52(6): 307.     CrossRef
  • Urachal borderline mucinous cystadenoma
    Jingjun Wu, Ailian Liu, Anliang Chen, Pengxin Zhang
    Medicine.2017; 96(47): e8740.     CrossRef
  • Incidental Finding of a Rare Urachal Pathology: Urachal Mucinous Cystic Tumour of Low Malignant Potential
    Luke L. Wang, Heath Liddell, Sharman Tan Tanny, Briony Norris, Sree Appu, David Pan
    Case Reports in Urology.2016; 2016: 1.     CrossRef
  • A Case of Borderline Mucinous Cystadenoma Thought to be of Urachal Origin
    Kiichiro YAGUCHI, Yoshihito GOMYO, Hiroyasu SAITO, Tatsuo IKENO, Hiromi SAKAGUCHI, Hideo MIYAMOTO
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(5): 1418.     CrossRef
  • An unexpected mass of the urachus: a case report
    Monica C. Pasternak, Jonathan D. Black, Natalia Buza, Masoud Azodi, Aileen Gariepy
    American Journal of Obstetrics and Gynecology.2014; 211(4): e1.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP